AU5155198A - Method and composition for transdermal administration of pharmacologic agent - Google Patents

Method and composition for transdermal administration of pharmacologic agent

Info

Publication number
AU5155198A
AU5155198A AU51551/98A AU5155198A AU5155198A AU 5155198 A AU5155198 A AU 5155198A AU 51551/98 A AU51551/98 A AU 51551/98A AU 5155198 A AU5155198 A AU 5155198A AU 5155198 A AU5155198 A AU 5155198A
Authority
AU
Australia
Prior art keywords
composition
transdermal administration
pharmacologic agent
pharmacologic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51551/98A
Inventor
Robert Murdock
C. Donald Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DONALD WILLIAMS C
Original Assignee
DONALD WILLIAMS C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DONALD WILLIAMS C filed Critical DONALD WILLIAMS C
Publication of AU5155198A publication Critical patent/AU5155198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
AU51551/98A 1997-08-28 1997-10-24 Method and composition for transdermal administration of pharmacologic agent Abandoned AU5155198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5712997P 1997-08-28 1997-08-28
US60057129 1997-08-28
PCT/US1997/019651 WO1999011208A1 (en) 1997-08-28 1997-10-24 Method and composition for transdermal administration of pharmacologic agents

Publications (1)

Publication Number Publication Date
AU5155198A true AU5155198A (en) 1999-03-22

Family

ID=22008683

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51551/98A Abandoned AU5155198A (en) 1997-08-28 1997-10-24 Method and composition for transdermal administration of pharmacologic agent

Country Status (2)

Country Link
AU (1) AU5155198A (en)
WO (1) WO1999011208A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6280763B1 (en) 1999-05-10 2001-08-28 Pierce Management, Llc Apparatus and method for transdermal delivery of bupropion
AU771258B2 (en) 1999-07-01 2004-03-18 Pharmacia & Upjohn Company Highly selective norepinephrine reuptake inhibitors and methods of using the same
SE9904750D0 (en) * 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
KR20020050135A (en) * 2000-12-20 2002-06-26 조명재 Compositions for prevention and alleviation of skin wrinkles
US6620405B2 (en) 2001-11-01 2003-09-16 3M Innovative Properties Company Delivery of hydrogel compositions as a fine mist
US7390885B2 (en) 2001-11-26 2008-06-24 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7365167B2 (en) 2001-11-26 2008-04-29 Cell Matrix, Inc. Humanized collagen antibodies and related methods
CN100393301C (en) * 2005-02-23 2008-06-11 华中科技大学 Molecular gel transdermal medicine preparation and its preparing method
WO2007056068A2 (en) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Macrocyclic formulations for transmembrane drug delivery
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE95430T1 (en) * 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh ACTIVE PATCHES.
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5292499A (en) * 1990-09-11 1994-03-08 University Of Wales College Of Cardiff Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion

Also Published As

Publication number Publication date
WO1999011208A1 (en) 1999-03-11

Similar Documents

Publication Publication Date Title
AU7601998A (en) Composition and methods for transdermal delivery of acid labile drugs
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
AU3654697A (en) Transdermal application of naturally occurring steriod hormones
NZ302926A (en) Composition for use as antihistamines comprising piperidinoalkanol derivatives and inert ingredients
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
AU8658498A (en) Delivery of agents and method for regeneration of periodontal tissues
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
AU1380699A (en) Composition and method for increasing insulin activity
AU6079598A (en) Additive preparation and method of use thereof
AU1307299A (en) Stable pharmaceutical compositions including ascorbic acid and methods of using same
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU1865199A (en) Composition and method for dermal and transdermal administration of a cytokine
EP0941039A4 (en) Transdermal administration of ment
AU5155198A (en) Method and composition for transdermal administration of pharmacologic agent
GB9710800D0 (en) Pharmaceutical composition and method of preparing it
AU4981896A (en) Liposome composition and method for administering liposome-loadable drugs
AU1705400A (en) Method and composition for treating and preventing tuberculosis
AU1429697A (en) Systems and methods for the transdermal administration of androgenic agents
ZA9670B (en) Composition and methods for transdermal delivery of acid-lability drugs
AU6605100A (en) Method and pharmaceutical composition for parenteral administration of iron
AUPO359396A0 (en) A method of treatment and pharmaceutical compositions useful for same
AU8490198A (en) Method and composition for causing skin lightening
AU3325095A (en) Composition and method for protection against drug dependency
AU1578695A (en) Desogestrel-containing transdermal application agent
AU732214C (en) Biphenyl derivatives and drug composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase